Comparison NLS Pharmaceutics (NCEL) with Competitors
NLS Pharmaceutics (NCEL) industry is Biotechnology.
Debt-to-Equity
NCEL4.90%
Industry28.27%
Upside-82.68%
Free Cash Flow Yield
NCEL-14.71%
Industry-1.75%
Upside-12.97%
P/E
NCEL-2.27
Industry-20.52
Upside+1824.57%
P/B
NCEL2.96
Industry5.15
Upside-42.55%